Trials / Completed
CompletedNCT01162876
A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics and pharmacodynamics of saxagliptin administered before breakfast for 14 consecutive days in patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | saxaglipitin | oral administration of 5 mg tablet before breakfast for 14 consecutive days |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-07-15
- Last updated
- 2017-03-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01162876. Inclusion in this directory is not an endorsement.